홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VRDN
#3856
Viridian Therapeutics, Inc. Common Stock
29.380
0
+2.98%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+2.98%
월간 변동
-12.59%
6달 변화
+30.87%
년간 변동율
+30.87%
이전 종가
28.530
0
Open
29.380
0
Bid
Ask
Low
29.380
0
High
29.380
0
양
105
마켓
주식
헬스케어
VRDN
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
7.23 M
25.91 M
42.9 M
62.77 M
81.48 M
102.21 M
—
Valuation ratios
Enterprise value
—
646.14 M
1.36 B
1.61 B
1.75 B
3.31 B
8.18 B
Price to earnings ratio
—
-2.97
-7.04
-4.21
0.05
0.07
0.14
Price to sales ratio
—
79.53
516.08
3 185.62
19.03
—
—
Price to cash flow ratio
—
4.32
9.75
5.43
0.02
0.03
0.09
Price to book ratio
—
4.37
3.62
4.25
0.01
0.01
0.03
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.84
-0.39
-0.3
-0.48
-0.36
0.38
-0.23
Return on equity %
-0.92
-0.42
-0.33
-0.54
-0.4
0.47
-0.24
Return on invested capital %
-15.85 K
-14.4 K
-16.57 K
-30.31 K
-32.85 K
30.88 K
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-10.51 K
-2 690.79
-7 579.23
-81.04 K
-99.02 K
512.91
-179.79 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-10.54 K
-2 680.16
-7 329.23
-75.71 K
-89.39 K
483.57
-163.9 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.14
14.68
12.93
18.26
15.43
12.65
54.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.01
0
0
0.09
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
-0.01
0.01
0.04
0.03
0.09
0.18
Long term debt to total equity ratio
0
-0.01
0.01
0.05
0.03
0.12
0.22
Per share metrics
Operating cash flow per share
—
-4.58
-2.92
-4.12
-775.13
1 009.69
-815.42
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
16.53
13.23
10.67
2 394.25
3 195.38
9 233.79
Net current asset value per share
—
16.79
13.44
10.87
2 463.85
3 266.74
9 722.97
Tangible book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
Working capital per share
—
15.65
12.4
10.27
2 304.12
3 008.48
8 975.44
Book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
뉴스
Stifel, Viridian Therapeutic에 ’매수’ 등급 재확인
Stifel reiterates Viridian Therapeutic stock rating on BLA review
제프리스, Viridian Therapeutics 목표 주가 상향 조정
Jefferies raises Viridian Therapeutic stock price target on trial progress
에버코어 ISI, Viridian Therapeutics에 대한 확신 재확인
Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Viridian Therapeutics Q4 실적, 수익 에상치보다 저조
Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
BB Biotech 2025 회계연도: 660% 이익 급증, 2026년 전망은 신중
트루이스트, Viridian Therapeutics 목표 주가 ’매수’ 유지